Development of a method of thymocyte differentiation of bone marrow-enriched CD34+CD38- cells in postnatal allogeneic cultured thymic epithelia to evaluate immunodeficiency disorders

Stem Cells
A P KnutsenJ D Bouhasin

Abstract

An in vitro model of CD34+CD38- stem cell (SC) differentiation in postnatal cultured thymic epithelia fragment (CTEF) cocultures is described. Sequential phenotypic analysis of the progeny of the SC-CTEF demonstrated predominantly thymocytes and minor populations of promyelocytes, monocytes and natural killer cells. Triple-positive CD3+CD4+CD8+, double-positive CD4+CD8+, and mature single-positive CD4+ and CD8+ T cells, which were TCR alpha beta+, were identified indicating normal thymocyte maturation. In kinetic studies, mature single-positive CD4+ T cells increased from 29% of total cells at one week to 54% at four weeks of coculture. These findings demonstrate that coculture of bone marrow-derived SC and allogeneic cultured thymic epithelia in vitro results in continuous normal predominantly thymocyte differentiation. The SC-CTEF cocultures were then infected with two different strains of human immunodeficiency virus. CD4+ thymocytes were markedly decreased. However, inhibition of early thymocyte maturation steps was also suggested by the presence of increased triple-negative and CD44+CD25-CD3-thymocytes and decreased CD44+CD25+ thymocytes. This model system of thymocyte maturation will be useful in the evaluation of primary...Continue Reading

References

Jan 1, 1991·Annual Review of Immunology·J McCuneM Lieberman
Jul 1, 1994·The Journal of Experimental Medicine·A BárcenaH Spits
Nov 1, 1994·Stem Cells·R H Collins
Nov 1, 1993·Immunology Today·D I Godfrey, A Zlotnik
Jun 24, 1993·Nature·M L BonyhadiH Kaneshima
Jul 1, 1993·The Journal of Experimental Medicine·D L KraftE K Waller
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M YuF Wong-Staal
Jun 24, 1993·Nature·G M AldrovandiJ A Zack
Jan 1, 1996·Nature Medicine·A R FreedmanD T Scadden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.